These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22228694)

  • 1. Biopharmaceutical process development - shortcut to market: an interview with Rolf Werner from Boehringer Ingelheim.
    Jungbauer A; Göbel U
    Biotechnol J; 2012 Jan; 7(1):14-6. PubMed ID: 22228694
    [No Abstract]   [Full Text] [Related]  

  • 2. In vogue with venture.
    Patou G
    Nat Biotechnol; 2011 Nov; 29(11):967-9. PubMed ID: 22175076
    [No Abstract]   [Full Text] [Related]  

  • 3. Biopharma deal-making in 2016.
    Micklus A; Muntner S
    Nat Rev Drug Discov; 2017 Mar; 16(3):161-162. PubMed ID: 28209988
    [No Abstract]   [Full Text] [Related]  

  • 4. Industry sponsored bias in cost effectiveness analyses.
    John-Baptiste A; Bell C
    BMJ; 2010 Oct; 341():c5350. PubMed ID: 20943724
    [No Abstract]   [Full Text] [Related]  

  • 5. A Market Shaping Approach for the Biopharmaceutical Industry: Governing Innovation Towards the Public Interest.
    Mazzucato M; Li HL
    J Law Med Ethics; 2021; 49(1):39-49. PubMed ID: 33966657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Market watch: industry perspectives on personalized medicine.
    Zuckerman R; Milne CP
    Nat Rev Drug Discov; 2012 Mar; 11(3):178. PubMed ID: 22378258
    [No Abstract]   [Full Text] [Related]  

  • 7. Vulnerability of health to market forces.
    Brezis M; Wiist WH
    Med Care; 2011 Mar; 49(3):232-9. PubMed ID: 21301368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Market access for biopharmaceuticals: new challenges.
    Simon F
    Health Aff (Millwood); 2006; 25(5):1363-70. PubMed ID: 16966734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopharmaceutical benchmarks--2003.
    Walsh G
    Nat Biotechnol; 2003 Aug; 21(8):865-70. PubMed ID: 12894198
    [No Abstract]   [Full Text] [Related]  

  • 10. Russia through the prism of the world biopharmaceutical market.
    Bairamashvili DI; Rabinovich ML
    Biotechnol J; 2007 Jul; 2(7):801-17. PubMed ID: 17615600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. India sets its sights on global health care market.
    Jayaraman KS
    Nat Med; 2003 Apr; 9(4):377. PubMed ID: 12669044
    [No Abstract]   [Full Text] [Related]  

  • 12. Mobile economics and pricing of health care services.
    Huttin CC
    Technol Health Care; 2012; 20(5):459-61. PubMed ID: 23079949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Market watch: upcoming market catalysts in Q4 2010.
    Rosenthal J
    Nat Rev Drug Discov; 2010 Oct; 9(10):755. PubMed ID: 20885399
    [No Abstract]   [Full Text] [Related]  

  • 14. For-profit clinical trials in developing countries--those troublesome patient benefits.
    Schuklenk U
    Am J Bioeth; 2010 Jun; 10(6):52-4. PubMed ID: 20526975
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceuticals and medical devices: business practices. Issue brief.
    Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-44. PubMed ID: 21374840
    [No Abstract]   [Full Text] [Related]  

  • 16. An audience with Luciano Rossetti. Interview by Bethan Hughes.
    Rossetti L
    Nat Rev Drug Discov; 2010 Oct; 9(10):758. PubMed ID: 20885401
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigating investment in biopharmaceutical R&D.
    Carter PH; Berndt ER; DiMasi JA; Trusheim M
    Nat Rev Drug Discov; 2016 Oct; 15(10):673-4. PubMed ID: 27616295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing medicines in line with global public health needs: the role of the World Health Organization.
    Pang T
    Camb Q Healthc Ethics; 2011 Apr; 20(2):290-7. PubMed ID: 21435304
    [No Abstract]   [Full Text] [Related]  

  • 19. Justice in the application of science: beyond fair benefits.
    London AJ
    Am J Bioeth; 2010 Jun; 10(6):54-6. PubMed ID: 20526976
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to open peer commentaries on "How to do research fairly in an unjust world".
    Ballantyne AJ
    Am J Bioeth; 2010 Jun; 10(6):W4-6. PubMed ID: 20526959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.